Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Biotechnology

1594

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine. In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides.
In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

All reports in Biotechnology

< prev 1  2  3  4  5  6  7  8  9  10  next >
541711 Research and Development In Biotechnology: State Industry Market Evaluator
6/1/2012 | published by: BizMiner
... industry market volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure rates (firms, establishments, small business, startups). startup ...  |  more...
$699.00
Freedonia Focus on Biotechnology -- Agriculture: United States
5/31/2012 | published by: Freedonia Focus
... industry composition; and leading participants. Product segments covered are transgenic seeds and plants, crop productivity and diagnostics, animal vaccines, and animal productivity and diagnostics. This 20 page report also includes a highlights summary and a ...  |  more...
$600.00
Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... focus is on the development of Eniluracil, an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, which it is developing to improve the tolerability and effectiveness of 5-fluorouracil (5-FU). Eniluracil is in Phase II trial for metastatic breast ...  |  more...
$125.00
Gilead Sciences, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Gilead ...  |  more...
$500.00
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
... target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the ...  |  more...
$3,995.00
Ardea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis Review
5/11/2012 | published by: GlobalData
... of gout and cancer. The product portfolio of the company includes three pipeline products, namely, Lesinurad (RDEA 594), RDEA 3170 and Bay 86-966 (RDEA 119). Lesinurad and RDEA 3170 are currently in Phase-III and Phase-I ...  |  more...
$125.00
Wound Care in Ukraine
5/10/2012 | published by: Euromonitor International
... which benefited wound care, as the economy recovered slowly from the financial crisis. Retail value sales increased by 11% in current terms to UAH141 million in 2011 – however, this represented slower growth than the ...  |  more...
$900.00
Wound Care in Guatemala
5/10/2012 | published by: Euromonitor International
... favour the performance of wound care, with around 42% of the population aged between 0-14-years of age. This large young population provides the category with a large current consumer base. Euromonitor International's Wound Care in ...  |  more...
$900.00
Wound Care in Dominican Republic
5/9/2012 | published by: Euromonitor International
... medical attention. These products are purchased without paying attention to brands due to limited differentiation. Euromonitor International's Wound Care in Dominican Republic report offers a comprehensive guide to the size and shape of the market ...  |  more...
$900.00
Wound Care in Latvia
5/8/2012 | published by: Euromonitor International
... new technologies or delivery formats, as a result such products as spray-on plasters were not present in Latvia. The major factor behind this was that producers wanted to develop more positive attitudes towards more expensive ...  |  more...
$900.00
Wound Care in Malaysia
5/3/2012 | published by: Euromonitor International
... label keen on product launches that follow closely behind those of branded players, which serve to minimise consumers’ perception of quality differences. Euromonitor International's Wound Care in Malaysia report offers a comprehensive guide to the ...  |  more...
$900.00
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ...  |  more...
$5,175.00
Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Celgene Corporation
5/1/2012 | published by: SGA Lists
... Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for ...  |  more...
$107.00
Novartis Consumer Health, Inc.
5/1/2012 | published by: SGA Lists
... Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for ...  |  more...
$36.00
Biotech Business - May 2012
5/1/2012 | published by: Worldwide Videotex
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline.  |  more...
$25.00
Ardea Biosciences, Inc.
5/1/2012 | published by: SGA Lists
... Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for ...  |  more...
$25.00
Commercializing Biomarkers in Therapeutic and Diagnostic Applications
5/1/2012 | published by: CHI Insight Pharma Reports
... biomarkers and successfully commercialize them in therapeutic and diagnostic applications. Included in this publication: Biomarker definitions and guidelines for their development and validation Applications of biomarkers in oncology, cardiology, neurology, drug safety, and other areas ...  |  more...
$3,195.00
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
5/1/2012 | published by: Current Partnering
... enter royalty financing deals. Comprehensive directory of royalty financing deals since 2007 Royalty financing contract documents Royalty financing agreement terms Royalty financing agreement structure Top royalty financing deals by value Most active Royalty financing dealmakers  |  more...
$2,695.00
Biotech Equipment Update - May 2012
5/1/2012 | published by: Worldwide Videotex
... product and technology announcements, as well as vendor research, development, and manufacturing information. Please Note: Due to the brevity and/or nature of the content posted, there is no table of contents available for this report.  |  more...
$25.00
Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
5/1/2012 | published by: Current Partnering
... Revised and updated 6th edition, includes: Trends in co-promotion and co-marketing deals Co-promotion and co-marketing agreement structure Co-promotion and co-marketing contract documents Top co-promotion deals by value Top co-marketing deals by value Most active co-promotion ...  |  more...
$2,695.00
Biotech Financial Reports - May 2012
5/1/2012 | published by: Worldwide Videotex
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements.  |  more...
$25.00
< prev 1  2  3  4  5  6  7  8  9  10  next >